[{"NetIncomeLoss_1_Q3_USD":-105139.0,"CommonStockSharesIssued_0_Q3_shares":2421106.0,"UnrecognizedTaxBenefits_0_Q3_USD":0.0,"RepaymentsOfRelatedPartyDebt_3_Q3_USD":175000.0,"TemporaryEquityCarryingAmountAttributableToParent_0_Q3_USD":75901950.0,"TemporaryEquitySharesOutstanding_0_Q3_shares":7590195.0,"AssetsCurrent_0_Q3_USD":881274.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q3_USD":89320.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-80090412.0,"CommitmentsAndContingencies_0_Q3_USD":null,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"ProceedsFromRelatedPartyDebt_3_Q3_USD":175000.0,"Liabilities_0_Q3_USD":89320.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":727926.0,"PaymentsOfStockIssuanceCosts_3_Q3_USD":256690.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":81063721.0,"AssetsHeldInTrustNoncurrent_0_Q3_USD":80110005.0,"EffectiveIncomeTaxRateContinuingOperations_3_Q3_pure":0.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_3_Q3_USD":88320.0,"UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_0_Q3_USD":0.0,"CommonStockValue_0_Q3_USD":242.0,"IncomeTaxExpenseBenefit_3_Q3_USD":0.0,"Assets_0_Q3_USD":80991279.0,"PrepaidExpenseCurrent_0_Q3_USD":153348.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"NetIncomeLoss_3_Q3_USD":-185762.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"AdditionalPaidInCapital_0_Q3_USD":5186529.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":727926.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-270383.0,"CommonStockSharesOutstanding_0_Q3_shares":2421106.0,"DeferredTaxAssetsGross_0_Q3_USD":39000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":702926.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-186762.0,"StockholdersEquity_0_Q3_USD":5000009.0,"ProfitLoss_3_Q3_USD":-185762.0,"DeferredTaxAssetsValuationAllowance_0_Q3_USD":39000.0,"ProceedsFromIssuanceOfWarrants_3_Q3_USD":2831809.0,"PreferredStockSharesAuthorized_0_Q3_shares":1000000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":80991279.0,"PreferredStockValue_0_Q3_USD":null,"InvestmentIncomeInterest_1_Q3_USD":14752.0,"InvestmentIncomeInterest_3_Q3_USD":19593.0,"OperatingIncomeLoss_1_Q3_USD":-119891.0,"OperatingIncomeLoss_3_Q3_USD":-205355.0,"CommonStockSharesAuthorized_0_Q3_shares":30000000.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":78488602.0,"IncreaseDecreaseInPrepaidExpense_3_Q3_USD":153348.0,"Ticker":"SNCE","CIK":"1819113","name":"LIFESCI ACQUISITION II CORP.","OfficialName":"Science 37 Holdings Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"516256808.0","Country":"United States","Sector":"Technology","Industry":"Computer Software: Prepackaged Software","Market":"NASDAQ","SP500":"nan","filed":"20210517"}]